← Leaderboards
Raymond Goodrich
Colorado State University
$6,280,811
Attributed
$6,280,811
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2020–24$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,280,811 · 1
By mechanism
N01$6,280,811 · 1
Top collaborators
No co-investigators on record.
Most similar at Colorado State University
Same institution · by research overlap
- Gregory David Ebel$18,531,280
- Lakshmi Prasad Dasi$5,854,593
- John Volckens$12,063,720
- Mary Jackson$25,157,631
- Mercedes Gonzalez-Juarrero$6,903,366
Others in their field
Other Emerging Leaders on “Vaccines”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$149,372,007
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Ted Ross · University Of Georgia$71,962,304
Research focus
VaccinesAnimal ModelEfficacy TestingEmerging Communicable DiseasesFormulationImmunogenicityResponseSafetyStability TestingToxicologyAdvanced DevelopmentCommunicable DiseasesContractsCovid-19 VaccineDisease OutbreaksEfficacy EvaluationCategoriesNational Institute Of Allergy And Infectious DiseasePriority PathogenManufactureBloodPathogenVaccine DevelopmentCovid-19
Grant awards (4)
To Develop and Manufacture an Inactivated SARS-CoV-2 Vaccine Using Blood Pathogen Reduction Technology$850,444
N01 · FY2024 · AI · contact PI
Development of a COVID-19 Vaccine$781,429
N01 · FY2023 · AI · contact PI
Development of a COVID-19 Vaccine$1,549,907
N01 · FY2021 · AI · contact PI
Development of a COVID-19 Vaccine$3,099,031
N01 · FY2020 · AI · contact PI